AU8240998A - Microparticles for controlled delivery of biologically active molecules - Google Patents

Microparticles for controlled delivery of biologically active molecules

Info

Publication number
AU8240998A
AU8240998A AU82409/98A AU8240998A AU8240998A AU 8240998 A AU8240998 A AU 8240998A AU 82409/98 A AU82409/98 A AU 82409/98A AU 8240998 A AU8240998 A AU 8240998A AU 8240998 A AU8240998 A AU 8240998A
Authority
AU
Australia
Prior art keywords
microparticles
biologically active
controlled delivery
active molecules
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82409/98A
Other languages
English (en)
Inventor
Anders Carlsson
Elisabetta Chiellini
Federica Chiellini
Jenny Cowdall
John Davies
Giuseppe Mazzanti
Mark Roberts
Erik Soderlind
Roberto Solaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Sierovaccinogeno Italiano (isi) SpA
Original Assignee
ISI IST SIEROVACCINOGENO ITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISI IST SIEROVACCINOGENO ITAL filed Critical ISI IST SIEROVACCINOGENO ITAL
Publication of AU8240998A publication Critical patent/AU8240998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU82409/98A 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules Abandoned AU8240998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
ITRM97A0418 1997-07-10
PCT/IT1998/000192 WO1999002135A1 (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules

Publications (1)

Publication Number Publication Date
AU8240998A true AU8240998A (en) 1999-02-08

Family

ID=11405168

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82409/98A Abandoned AU8240998A (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules

Country Status (7)

Country Link
EP (1) EP1003482B1 (enExample)
AT (1) ATE293958T1 (enExample)
AU (1) AU8240998A (enExample)
DE (1) DE69829975T2 (enExample)
ES (1) ES2242287T3 (enExample)
IT (1) IT1293088B1 (enExample)
WO (1) WO1999002135A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
DE60232149D1 (de) 2001-06-20 2009-06-10 Dainippon Sumitomo Pharma Co Verfahren zur förderung des nukleinsäuretransfers
JP2008067717A (ja) * 2001-06-20 2008-03-27 Dainippon Sumitomo Pharma Co Ltd 核酸導入を促進させる方法
US7186692B2 (en) 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
EA008829B1 (ru) 2002-12-17 2007-08-31 Нэстек Фармасьютикал Кампани Инк. Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
CA3004363A1 (en) 2015-11-06 2017-05-11 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660556B1 (fr) * 1990-04-06 1994-09-16 Rhone Poulenc Sante Microspheres, leur procede de preparation et leur utilisation.
IT1244511B (it) * 1991-04-15 1994-07-15 Isi Ist Sierovaccinogeno Ital Idrogeli a base di policarbossilati sintetici e proteine per il rilascio controllato di farmaci e procedimento per la loro preparazione.
CA2136434C (en) * 1992-06-11 2008-12-02 Howard Bernstein Erythropoietin drug delivery system
CA2160878A1 (en) * 1993-04-19 1994-10-27 Sandra Gertrude Mcelligott Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression

Also Published As

Publication number Publication date
IT1293088B1 (it) 1999-02-11
EP1003482A1 (en) 2000-05-31
EP1003482B1 (en) 2005-04-27
ITRM970418A1 (it) 1999-01-10
ES2242287T3 (es) 2005-11-01
ITRM970418A0 (enExample) 1997-07-10
DE69829975D1 (de) 2005-06-02
DE69829975T2 (de) 2006-03-09
ATE293958T1 (de) 2005-05-15
WO1999002135A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
ATE392202T1 (de) Spritzgiessbare feste verabreichungsysteme
DK1367944T3 (da) Plaster til skanning af et individs overfölsomhedstilstand for et allergen
AU1728901A (en) Electropolymerizable monomers and polymeric coatings on implantable devices
DE69821510D1 (de) Mit apatit beschichtete feste zusammensetzung
DE69823055D1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
ATE307620T1 (de) Implantatmaterial mit glaspartikeln
SE9201128D0 (sv) Artificial filling and prosthetic material
AU8240998A (en) Microparticles for controlled delivery of biologically active molecules
ATE467430T1 (de) Endovaskuläres implantat mit einer zumindest abschnittsweisen aktiven beschichtung aus ratjadon und/oder einem ratjadon-derivat
DE69801517D1 (de) Verfahren zur verhinderung der verkalkung von aldehyd-fixierten bioprothesenmaterialien
AU5795896A (en) Controlling the porosity and permeation of a web
EP1561461A3 (en) Adhesive mixture for transdermal delivery of highly plasticizing drugs
EA200000278A1 (ru) Композиционный материал на основе бумаги с полимерным покрытием
DE69637995D1 (de) Permeabele formkörper aus aktiven partikeln verbunden mit mikropartikeln aus haftklebemittelpolymer
AU9574198A (en) Method of affinity cross-linking biologically active, immunogenic peptides to antibodies
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
DE59506057D1 (de) Kollagenzubereitung zur gesteuerten abgabe von wirkstoffen
ATE223206T1 (de) Verfahren zur herstellung von mikropartikeln
ES2163180T3 (es) Estructura absorbente que contiene un polimero altamente absorbente y articulo absorbente que contiene esta estructura absorbente.
AU763798B2 (en) Plaster containing an active agent
ES2176459T3 (es) Patrones y soluciones de contraste estabilizados.
NO981864L (no) Oppl°sningsmetoder
DE69627880D1 (de) Diltiazemhaltige mikrogranulate mit verzögerter wirkstoffabgabe
EP1106189A3 (en) Photo-curing tissue adhesive
ID16653A (id) Komposisi pelapis polimer-polimer flour dan benda yang dilapisi dengan komposisi tersebut.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase